Sian Fereday Selected Research

Aftercare (After-Treatment)

1/2018

Response rates to second-line platinum-based therapy in ovarian cancer patients challenge the clinical definition of platinum resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sian Fereday Research Topics

Disease

19	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 08/2008
16	Neoplasms (Cancer) 01/2021 - 08/2008
12	Carcinoma (Carcinomatosis) 01/2020 - 02/2009
3	Ovarian Epithelial Carcinoma 01/2020 - 01/2018
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2019
2	Residual Neoplasm 01/2020 - 09/2008
2	Endometrioid Carcinoma 08/2013 - 10/2010
1	Endometriosis 01/2022
1	Inflammation (Inflammations) 01/2022
1	Pelvic Inflammatory Disease (Pelvic Inflammatory Diseases) 01/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 01/2022
1	Nevus (Nevi) 01/2021
1	Turcot syndrome 01/2020
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Sarcoma (Soft Tissue Sarcoma) 11/2018
1	Obesity 04/2014
1	Overweight 04/2014

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2021 - 08/2013
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2009
4	PlatinumIBA 01/2019 - 02/2009
4	Proteins (Proteins, Gene)FDA Link 10/2018 - 02/2009
3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 09/2008
2	Hormones (Hormone)IBA 01/2022 - 08/2013
2	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
2	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2019
2	Biological ProductsIBA 01/2021 - 08/2008
2	ChromatinIBA 01/2021 - 12/2016
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2019 - 09/2008
2	taxaneIBA 01/2018 - 09/2008
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2017 - 07/2012
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	Talc FDA Link 01/2022
1	SmokeIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Small Cytoplasmic RNAIBA 01/2021
1	Formaldehyde (Formol)FDA Link 01/2021
1	ParaffinIBA 01/2021
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	Progesterone Receptors (Progesterone Receptor)IBA 01/2020
1	Messenger RNA (mRNA)IBA 01/2019
1	CA-125 Antigen (CA 125 Antigen)IBA 11/2018
1	dabrafenibIBA 11/2018
1	Mitogen-Activated Protein KinasesIBA 11/2018
1	Toll-Like Receptor 4IBA 01/2018
1	TransducinIBA 01/2018
1	Retinoblastoma ProteinIBA 01/2018
1	Circulating Tumor DNAIBA 04/2017
1	Cell-Free Nucleic AcidsIBA 04/2017
1	Ligases (Synthetase)IBA 12/2016
1	UbiquitinIBA 12/2016
1	Indicators and Reagents (Reagents)IBA 12/2014
1	liposomal doxorubicin (Doxil)FDA Link 08/2012
1	OligonucleotidesIBA 02/2009
1	Cadherins (E-Cadherin)IBA 08/2008
1	Differentiation AntigensIBA 08/2008

Therapy/Procedure

12	Drug Therapy (Chemotherapy) 01/2021 - 09/2008
6	Therapeutics 01/2022 - 01/2013
1	Aftercare (After-Treatment) 01/2018
1	Neoadjuvant Therapy 09/2016
1	Combination Drug Therapy (Combination Chemotherapy) 05/2015